BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 27847107)

  • 1. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Del Carmen MG; Rice LW
    Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidisciplinary International Conference on Gynecologic Cancer, Bologna, Italy, June 8-12, 2005.
    Bovicelli A; D'Andrilli G; Giordano A
    J Cell Physiol; 2006 Jul; 208(1):1-5. PubMed ID: 16557531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor markers in gynecological tumors.
    Rustin GJ
    Curr Opin Oncol; 1996 Sep; 8(5):426-31. PubMed ID: 8914810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights from the Society of Gynecologic Oncology's 50th Annual Meeting on Women's Cancer.
    English DP; Huang M
    Gynecol Oncol; 2019 Jun; 153(3):467-470. PubMed ID: 31023555
    [No Abstract]   [Full Text] [Related]  

  • 5. Meeting report from the 2020 Annual (virtual) Meeting of the American Society of Clinical Oncology.
    Salani R; Liu JF
    Gynecol Oncol; 2020 Oct; 159(1):13-16. PubMed ID: 32771275
    [No Abstract]   [Full Text] [Related]  

  • 6. Gynecologic cancers.
    Blair AR; Casas CM
    Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic malignancies.
    Whitcomb BP
    Surg Clin North Am; 2008 Apr; 88(2):301-17, vi. PubMed ID: 18381115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of malignant tumors in gynecology].
    Ledermair O; Michlmayr G; Hammer J
    Wien Med Wochenschr; 1986 Jun; 136(11-12):307-11. PubMed ID: 3751078
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer.
    Kim YB; Ghosh K; Ainbinder S; Berek JS
    Cancer Treat Res; 1998; 95():253-76. PubMed ID: 9619288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting highlights: International Gynecologic Cancer Society (IGCS 2012).
    Eiriksson L; Reade CJ; Elit L
    Gynecol Oncol; 2013 Jan; 128(1):12-4. PubMed ID: 23397599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of gynecologic tumors during pregnancy.
    Roberts JA
    Clin Perinatol; 1983 Jun; 10(2):369-82. PubMed ID: 6352143
    [No Abstract]   [Full Text] [Related]  

  • 12. Gynaecologic cancer complicating pregnancy: an overview.
    Amant F; Brepoels L; Halaska MJ; Gziri MM; Calsteren KV
    Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):61-79. PubMed ID: 19740709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecologic malignancies of the elderly.
    Weintraub NT; Freedman ML
    Clin Geriatr Med; 1987 Nov; 3(4):669-94. PubMed ID: 3315162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic approaches in gynecologic oncology.
    Kucera PR
    Clin Lab Med; 1995 Sep; 15(3):743-70. PubMed ID: 8542732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of gynecologic malignancies.
    Ascher SM; Takahama J; Jha RC
    Top Magn Reson Imaging; 2001 Apr; 12(2):105-29. PubMed ID: 11296804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment modalities for gynecological cancers.
    Robertson C
    Semin Oncol Nurs; 1986 Nov; 2(4):275-80. PubMed ID: 3641348
    [No Abstract]   [Full Text] [Related]  

  • 17. The American Society of Clinical Oncology 2021 annual (virtual) meeting: A review and summary of selected abstracts.
    Salani R; Liu JF
    Gynecol Oncol; 2021 Aug; 162(2):245-248. PubMed ID: 34210516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.
    Smaletz O; Diz MD; do Carmo CC; Sabbaga J; Cunha-Junior GF; Azevedo SJ; Maluf FC; Barrios CH; Costa RL; Fontana AG; Madrigal V; Wainstein AJ; Yeda FP; Alves VA; Moro AM; Blasbalg R; Scott AM; Hoffman EW
    Gynecol Oncol; 2015 Aug; 138(2):272-7. PubMed ID: 26026738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.